Navigation Links
CTi’s Technology Highly Applicable in “Frack Water” and Waste Water Treatment
Date:7/11/2013

Chatsworth, California (PRWEB) July 11, 2013

Cavitation Technologies, Inc. announced today that the Company will commence trial testing of it’s Cavitation Electrocoagulation System with several “frack water” and wastewater treatment facilities within the U.S.

CTi’s Electrocoagulation System provides an innovative and efficient solution for the treatment of wastewater. More importantly, because of the system’s low electricity requirements and miniaturization of needed power supplies, the system can dramatically reduce operating costs compared to conventional wastewater treatment methods.

Roman Gordon, the company’s CTO, added, “Our Cavitation waste water system has demonstrated it can dramatically minimize the presence of heavy metals, oil emulsions, fats, grease, bacteria, viruses, and cysts in an environmentally sound and cost-effective manner. Our Cavitation technology and Electrocoagulaiton process provides the opportunity to maximize the beneficial re-use of resource materials, minimize transportation and disposal costs, as well as their associated liabilities.”

Additionally, Gordon noted that the potential applications of CTi’s system are infinite, as waste water treatment plays a vital role in food, beverage, pharmaceutical, pulp and paper, textiles, manufacturing, marine industry, mining process water, municipal water management, and automotive uses. The Company plans to begin utilizing the system in fiscal 2014 and will identify strategic partners accordingly.

About CTI
Founded in 2007, the company designs and manufactures state-of-the-art, flow-through, robust devices and systems and develops processing technologies for use in edible oil refining, renewable fuel production, expeditious petroleum upgrading, algal oil extraction, alcoholic beverage enhancement and water treatment. As an add-on to existing neutralization systems, the company’s patented NanoReactor™ allows refiners to significantly reduce both processing costs and the environmental impact, while also increasing the yield. More information is available at http://www.ctinanotech.com/.

The foregoing press release may contain forward-looking statements, including statements regarding, among other things, about the expectation of CTI's future business. These forward-looking statements are based largely on the Company's expectations and are subject to a number of risks and uncertainties, certain of which are beyond the Company's control. Actual results could differ materially from these forward looking statements as a result of a variety of factors including, among others, the state of the economy, the competitive environment, and the Company's performance. In light of these risks and uncertainties there can be no assurances that the forward looking statements contained in this press release will in fact transpire or prove to be accurate.

Read the full story at http://www.prweb.com/releases/2013/7/prweb10917760.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Desmet Ballestra Will Install CTI’s System at Edible Oil Refinery in Ecuador
2. PathoGenetix to Debut New Genotyping Technology for Rapid Strain Typing at IAFP
3. Research Shows That SurePure Technology Offers Alternative to Thermal Pasteurization of Human Breast Milk
4. TriMix for Travel Now Available at KRS Global Biotechnology
5. Official Opening of UKs Biggest Bioethanol Plant Using Praj Technology
6. CEM Introduces New Breakthrough Technology for Microwave Peptide Synthesis
7. iBio Pharmaceutical Technology Embraced by the Government of Brazil
8. Vinno Technology Co. Ltd Announced a Winner of the Renowned Platinum A' Design Award
9. City of Bellevue, Wash., Welcomes Assistive Technology Exhibit Hall
10. Clinverse, Inc. Exhibiting and Showcasing Its Technology at DIA 2013
11. Innovative Drug Delivery Systems: Novel Product and Formulation Technology Licensing Opportunities for Generic Pharmaceutical Companies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/5/2016)... 5, 2016 Australian-US drug discovery and development company, ... appointment of a new Chairman, Mr John O,Connor , ... immediately. James Garner , has also been ... former Acting CEO, Mr Iain Ross , will resume ... --> James Garner , has also been formally appointed ...
(Date:2/4/2016)... ... February 04, 2016 , ... Shimadzu Scientific Instruments will showcase ... demos and poster sessions, and present on the analysis of mycotoxins and medical ... 6 to 10 at the Georgia World Congress Center in Atlanta, Georgia. ...
(Date:2/4/2016)... PARK, Calif. , Feb. 4, 2016   DelMar ... biopharmaceutical company focused on the development and commercialization of new ... 18 th Annual BIO CEO & Investor Conference ... in New York, NY . ... an update on the ongoing clinical trial of VAL-083 ...
(Date:2/4/2016)... , Feb. 4, 2016 Sinovac Biotech Ltd. ... leading provider of biopharmaceutical products in China ... its board of directors received on February 4, 2016 ... from a consortium comprised of PKU V-Ming ( ... Co., Ltd., CICC Qianhai Development ( Shenzhen ...
Breaking Biology Technology:
(Date:1/25/2016)... , Jan. 25, 2016  Glencoe Software, the world-leading ... and publication industries, will provide the data management solution ... (NPSC). ... Phenotypic analysis measures the ... organisms, allowing comparisons between states such as health and ...
(Date:1/20/2016)...   MedNet Solutions , an innovative SaaS-based eClinical ... research, is pleased to announce the attainment of record-setting ... result of the company,s laser focus on (and growing ... it,s comprehensive, easy-to-use and highly affordable cloud-based technology platform. ... MedNet growth achievements in 2015 include: , ...
(Date:1/13/2016)... , January 13, 2016 ... the addition of the  "India Biometrics ... & Forecast (2015-2020)"  report to ... ) has announced the addition of ... Market - Estimation & Forecast (2015-2020)" ...
Breaking Biology News(10 mins):